NCT00134368View on ClinicalTrials.gov

Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

December 31, 2007

Conditions
Vitiligo
Interventions
DRUG

Etanercept

Trial Locations (1)

08903

UMDNJ Psoriasis Center of Excellence, New Brunswick

All Listed Sponsors
lead

University of Medicine and Dentistry of New Jersey

OTHER

NCT00134368 - Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo | Biotech Hunter | Biotech Hunter